HK37391A - Antidepressant 1,2,4-triazolone compounds - Google Patents

Antidepressant 1,2,4-triazolone compounds Download PDF

Info

Publication number
HK37391A
HK37391A HK373/91A HK37391A HK37391A HK 37391 A HK37391 A HK 37391A HK 373/91 A HK373/91 A HK 373/91A HK 37391 A HK37391 A HK 37391A HK 37391 A HK37391 A HK 37391A
Authority
HK
Hong Kong
Prior art keywords
antidepressant
triazolone compounds
compounds
triazolone
phenoxyalkyl
Prior art date
Application number
HK373/91A
Other languages
English (en)
Inventor
E. Gammans Richard
W. Smith David
P. Yevich Joseph
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK37391(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK37391A publication Critical patent/HK37391A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK373/91A 1983-09-30 1991-05-16 Antidepressant 1,2,4-triazolone compounds HK37391A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (1)

Publication Number Publication Date
HK37391A true HK37391A (en) 1991-05-24

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
HK373/91A HK37391A (en) 1983-09-30 1991-05-16 Antidepressant 1,2,4-triazolone compounds

Country Status (25)

Country Link
US (1) US4613600A (OSRAM)
JP (1) JPS60100560A (OSRAM)
KR (1) KR880002624B1 (OSRAM)
AT (1) AT387963B (OSRAM)
AU (1) AU561460B2 (OSRAM)
BE (1) BE900714A (OSRAM)
CA (1) CA1237723A (OSRAM)
CH (1) CH661924A5 (OSRAM)
CY (1) CY1541A (OSRAM)
DE (1) DE3435745C2 (OSRAM)
DK (1) DK169546B1 (OSRAM)
ES (1) ES536286A0 (OSRAM)
FI (1) FI83310C (OSRAM)
FR (1) FR2552759B1 (OSRAM)
GB (1) GB2147297B (OSRAM)
GR (1) GR80475B (OSRAM)
HK (1) HK37391A (OSRAM)
IE (1) IE58084B1 (OSRAM)
IT (1) IT1178522B (OSRAM)
LU (1) LU85561A1 (OSRAM)
MY (1) MY102123A (OSRAM)
NL (1) NL8402946A (OSRAM)
SE (1) SE465928B (OSRAM)
YU (1) YU45667B (OSRAM)
ZA (1) ZA847589B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
AU4215300A (en) 1999-04-09 2000-11-14 Sepracor, Inc. R-hydroxynefazodone
CA2369225A1 (en) 1999-04-09 2000-10-19 Sepracor Inc. S-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
EP3395372B1 (en) 2009-02-20 2022-04-06 EnhanX Biopharm Inc. Glutathione-based drug delivery system
SG10201402069PA (en) 2009-05-06 2014-07-30 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
AU2012304407A1 (en) 2011-09-09 2014-04-24 Children's Hospital & Research Center Oakland Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
SE8404869D0 (sv) 1984-09-28
DK468284D0 (da) 1984-09-28
MY102123A (en) 1992-03-31
IT1178522B (it) 1987-09-09
GR80475B (en) 1985-01-31
FI843779A0 (fi) 1984-09-26
FI83310B (fi) 1991-03-15
FI843779L (fi) 1985-03-31
LU85561A1 (fr) 1985-06-04
ATA310884A (de) 1988-09-15
GB2147297A (en) 1985-05-09
KR880002624B1 (ko) 1988-12-07
ZA847589B (en) 1985-05-29
BE900714A (fr) 1985-03-28
IE58084B1 (en) 1993-06-30
DE3435745A1 (de) 1985-04-11
AU3364884A (en) 1985-04-04
ES8601966A1 (es) 1985-11-16
YU172184A (en) 1986-10-31
CH661924A5 (de) 1987-08-31
IT8422922A0 (it) 1984-09-28
NL8402946A (nl) 1985-04-16
CA1237723A (en) 1988-06-07
SE8404869L (sv) 1985-03-31
YU45667B (sh) 1992-07-20
FI83310C (fi) 1991-06-25
CY1541A (en) 1991-03-22
GB8424535D0 (en) 1984-11-07
KR850002270A (ko) 1985-05-10
ES536286A0 (es) 1985-11-16
AU561460B2 (en) 1987-05-07
AT387963B (de) 1989-04-10
GB2147297B (en) 1987-04-15
US4613600A (en) 1986-09-23
DK169546B1 (da) 1994-11-28
JPH0542435B2 (OSRAM) 1993-06-28
DK468284A (da) 1985-03-31
IE842476L (en) 1985-03-30
FR2552759B1 (fr) 1988-10-07
FR2552759A1 (fr) 1985-04-05
JPS60100560A (ja) 1985-06-04
DE3435745C2 (de) 1994-11-03
SE465928B (sv) 1991-11-18

Similar Documents

Publication Publication Date Title
HK37391A (en) Antidepressant 1,2,4-triazolone compounds
TR199802691T1 (xx) Pestisid etkili 3-(ikameli fenil)-5-(tienil ya da furil)-1,2,4-triazoller
DK89595A (da) Fremgangsmåde til fremstilling af 1-(3-dimethylaminopropyl)-1'-(4-fluorphenyl)-1,3-dihydroisobenzofuran-5-carbonnitril
TR200001603T2 (tr) Yeni bileşikler
AT382373B (de) Verfahren zur herstellung von neuen 2-(4-(4,4dialkyl-2,6-piperidin-dion-1-yl)-butyl)-1piperazinyl)-pyrimidinen
RU93052411A (ru) (-)-энантиомер-{([4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил])-гидразоно} пропандинитрил
ATE236153T1 (de) 4-trifluormethyl-3-oxazolylpyridine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schädlingsbekämpfungsmittel
DE69106199D1 (de) Heterocyclische Acetonitrile und ihre Verwendung als Fungizide.
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
KR960016716A (ko) 테트라졸리논
FI852423A0 (fi) 1-(bis-(4-fluorofenyl)-metyl)- 4-(3-fenyl-2-propenyl)-hexahydro-1h-1,4-diazepin med kalciumantagonistverkan, dess framstaellning och kompositioner innehaollande densamma.
EP0995430A3 (de) Verwendung von Wirkstoffen, gewählt aus der Gruppe der 1,2-Diacylglycerole, zur Stärkung der Barrierefunktion der Haut
KR940005592A (ko) 살균제(2- 아릴- 2- 치환)에틸-1, 2, 4- 트리아졸들
DK1123291T3 (da) Fremgangsmåde til fremstilling af 3-(substitueret phenyl)-5-thienyl (eller furyl)-1,2,4-triazoler og hidtil ukendte mellemprodukter anvendt derved
ES2001809A6 (es) Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas
ATE307578T1 (de) Neue verwendung von (r)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylam nomethyl)-chromane und ihrer physiologisch verträglichen salze
DK0591236T3 (da) Fremgangsmåde til fremstilling af 5-(3-butyryl-2,4,6-trimethyl)-2-(1-(ethoxyimino)propyl)-3-hydroxycyklohex-2-en-1-on
IT8023422A0 (it) 5-(4-piridinil)-2 (1h)-piridinoni, utili come agenti cardiotonici, eloro preparazione.
KR970702275A (ko) 1-[5-메탄설폰아미도인돌릴-2-카보닐1-4-[3- -2-피리디 닐]피페라진의 신규한 결정 형태(NOVEL CRYSTAL FORMS OF 1-[5- METHANESULFONAMIDOlNDOLYL-2-CARBONYL]-4-[3-(1-METHYL- ETHYLAMINO)-2-PYRIDINYL]PIPERAZINE
ZA816489B (en) Pharmacologically active 4-(2-hydroxy-4-(substituted)phenyl)-naphthalen-2(1h)-ones and 2-ols,derivatives thereof and intermediates therefor
IL71859A (en) 3-(1,3-dioxolan-2-yl)-pyridine derivatives,their production and their use as microbicides
ATE35410T1 (de) Herstellung von 1-(3,4-dimethoxyphenylethylamino)-3-(substituie te phenoxy)-2-propanolen.
EP0232205A3 (en) Diene derivatives and vasodilators containing the same
DE69940922D1 (de) Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on
EP0174584A3 (de) Salicylamid-Derivate

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20040927

PE Patent expired